The study was to investigate the risks in the Pharmaceutical Supply Chain in Ghana. Questionnaire was the main instrument used for the data collection and the responses were analysed using SPSS. Sample size of Eighty (80) was used for the analysis. Data analysis was descriptive. The study revealed that Drug Shortages, Pilfering and Expiration of Drugs are the risks associated with the Pharmaceutical Supply Chain. The major reasons given for the occurrence of the risks include difficulty in obtaining raw materials, unethical attitude of pharmacists and chemical sellers, low income of consumers, poor inventory management and reverse logistics not being encouraged in the pharmaceutical industry in Ghana. The paper recommends the integration of Information and Communication Technology (ICT) tools in the management of inventory and also the strengthening of the Pharmaceutical Supply Chain. These measures would go a long way to reduce if not completely eliminated the exposure of the Pharmaceutical Supply Chain to risks.
Bradley, S. E., & Weber, J. (2004). “The Pharmaceutical Industry: The Challenges in the New Century.” Harvard Business School Case Study, 9-703-489.
Chopra, S., & Sodhi, M.S. (2004). “Managing risk to avoid supply chain breakdown."
Sloan Management Review, Fall, pp. 53-61.
Christopher, M. (2005). “Logistics and Supply Chain Management.” (3rd ed), London: FT
Prentice Hall.
Cockburn, R., Newton, P.N., Agyarko, E.K., Akunyili, D., & White, N.J. (2005). The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. PLOS Med 2(4): 100
Cooper, M., Dozuglas, L. & Pagh, J.D. (1997). “Supply chain management: more than a
new name for logistic.” International Journal of Logistics Management, Vol 8
(1), pp. 1-14
Ghana National Drug Policy (July 2004). “Ministry of Health, Ghana.” (2nd edition)
www.Ghana National_DrugPolicy2nd_Edition.pdf.Accessed on 7th January,2008
Handfield, R.B., & Nichols, E.L. (2002). “ Supply Chain Redesign: Transforming Supply Chains into Integrated Value Systems.” Financial Times,
Englewood Cliffs, NJ: Prentice-Hall,
Johnston, H. (2004). “Drug Shortages and Availability.” HDMA News Media
Lambert, D.M., and Cooper, M.C. (2000). “Issues in supply chain management.”
Industrial Marketing Management, Vol. 29, pp. 65-83
Lee, H.L., & Whang, S. (2000). "Information sharing in a supply chain", International
Journal of Technology Management, Vol. 20(3), pp.373-83.
Mahender ,S.,( May 6th, 2005). ‘The Pharmaceutical Supply Chain: a Diagnosis of the
State-of-the-Art’ Thesis Submitted to the Engineering Systems Division
for the Degree of Master of Engineering in Logistics. The University of
Tennessee, Massachusetts Institute. Supervisors: Professor Charles H. Fine and
Professor Yossi Sheffi.
Mentzer, T., de Witt, W., Keebler, J., Min, S., Nix, N., Smith, C. and Zacharia, Z. (2001)
“Defining supply chain management.” Journal of Business Logistics, Vol. 22
(2), pp. 1-26.
Narayanan, V.G., and Raman, A. (2004). “Aligning incentives in supply chains”, Harvard
Business Review, Vol. 82(11), pp. 94-102.
Norrman, A. and Jansson, U. (2004). "Ericsson's proactive supply chain risk management
approach after a serious sub-supplier accident." International Journal of
Physical Distribution & Logistics Management, Vol. 34 (5), pp.434-56.
Emerald Group Publishing Limited
PhRMA, (2004), “Pharmaceutical Industry Profile 2004.” Pharmaceutical
Research and Manufacturers of America (PhRMA), Washington, DC.
Poole, N.D. (1997). “Change in the European food industry: a research agenda
for marketing economists.” Journal of International Food and
Agribusiness Marketing.
Shemwell, D.J., Yavas, U. and Bilgin, Z. (1998).“Customer-service provider
relationships: An empirical test of a model of service quality, satisfaction and
relationship oriented outcome.” International Journal of Service Industry
Management, Vol. 9, pp. 155-68.
Treleven, M., and Schweikhart, S.B. (1988). "A risk/benefit analysis of sourcing
strategies: single vs multiple sourcing", Journal of Operations Management,
Vol. 7(4), pp.93-114 Publishers Inc.
Tyler, L. S., & Mark, S. M. (2002). “Understanding & Managing Drug
Shortages.” Proceedings of a breakfast symposium held during the 37th ASHP
Midyear Clinical Meeting Understanding & Managing, December 9, 2002.
United States Environmental Protection Agency (April 2004). General Risk Management
Program Guidance. US.E.P.A.
http://yosemite.epa.gov/oswer/ceppoweb.nsf/content/EPAguidance.htm#General.
Retrieved on 2008-05-26.
Zsidisin, G., Panelli, A. & Upton, R. (2000). "Purchasing organization involvement in
risk assessment, contingency plans, and risk management: an exploratory study."
Supply Chain Management: An International Journal, Vol. 5 No.4, pp.187-97.
Brako, S., Asante, D., & Akosah, N. B. (2016). Investigating the Risks in the Pharmaceutical Supply Chain in Ghana. International Journal of Academic Research in Business and Social Sciences, 6(6), 7-19.
Copyright: © 2016 The Author(s)
Published by Human Resource Management Academic Research Society (www.hrmars.com)
This article is published under the Creative Commons Attribution (CC BY 4.0) license. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this license may be seen at: http://creativecommons.org/licences/by/4.0/legalcode
